Graphene-based fluorescent biosensors for detecting biomolecules, nucleic acids, biomarkers, pathogens, food toxins, metal ions and pesticidesa.
| Biosensor type | Graphene-based nanocomposites | Target | Linear range | Limit of detection (LOD) | Ref. |
|---|---|---|---|---|---|
| Biomolecules | Tyramine-functionalized GQDs | Glucose | 50 nM to 2 μM | 7.2 nM | 670 |
| Tyramine-functionalized GQDs | H2O2 | 1 nM to 150 nM | 0.32 nM | 670 | |
| Tyramine-functionalized GQDs | Cholesterol | 80 nM to 10 μM | 1.2 nM | 670 | |
| Tyramine-functionalized GQDs | l-Lactate | 200 nM to 25 μM | 47 nM | 670 | |
| Tyramine-functionalized GQDs | Xanthene | 100 nM to 18 μM | 32 nM | 670 | |
| PVA/GQDs | Glucose | 0.25–24 mM | 10 μM | 671 | |
| PVA/GQDs | H2O2 | 0.05–35 mM | 1.0 μM | 671 | |
| GLY-GQDs | Ce4+ | 0.03–17.0 μM | 25 nM | 672 | |
| Nucleic acids | GO | miRNA | 0.02–100 fM | 3 fM | 673 |
| GO | miRNA | 10 fM to 10 pM | 3 fM | 674 | |
| rGO | Hepatitis B virus (HBV) | 0.05 pg mL−1 to 1 ng mL−1 | 0.05 ng mL−1 | 675 | |
| Biomarkers | GQDs | Cardiac marker antigen troponin I (cTnI) | 0.001–1000 ng mL−1 | 0.192 pg mL−1 | 676 |
| GR | PSA | 100–500 ng mL−1 | 100 ng mL−1 | 677 | |
| Pathogens | GQDs/AuNPs | S. aureus | 100 pM to 100 nM | 1 nM | 678 |
| GR magnetic nanosheets/CS | P. aeruginosa | 4.5 × 102 to 5 × 102 CFU mL−1 | 5 CFU mL−1 | 679 | |
| S. aureus | 4.5 CFU mL−1 | ||||
| GR sheets | Oxytetracycline | 0.01–0.2 μM | 0.01 μM | 680 | |
| GO/nucleic-acid stabilized Ag nanoclusters hybrid | DNA | 0–1000 nM | 0.5 nM | 681 | |
| ATP | 2.5 nM | ||||
| Thrombin | 0.5 nM | ||||
| Food toxins | GO/UC NPs | Ochratoxin A (OTA) | 0.05–100 ng mL−1 | 0.02 ng mL−1 | 682 |
| Aflatoxin B1 (AFB1) | 0.1–500 ng mL−1 | 0.1 ng mL−1 | |||
| GO | OTA | 2.0–35 μM | 1.9 μM | 683 | |
| CdTe QDs/GO | AFB1 | 3.2 nM to 320 μM | 1 nM | 684 | |
| GQDs | OTA | 0.05–20 ng mL−1 | 13 pg mL−1 | 685 | |
| GO/Au nanocomposite | AFB1 | 0.1–10 pg mL−1 | 0.03 pg mL−1 | 686 | |
| Metal ions | GR/DNAzymes complex | Cu2+ | 0–250 nM | 2 nM | 687 |
| GR/DNAzyme | Cu2+ | 0.01–1.5 μM | 0.365 nM | 688 | |
| GR/DNAzyme | Pb2+ | 0.5 nM to 2 μM | 0.5 nM | 689 | |
| GQDs/DNA | Hg2+ | 1 nM to 10 μM | 0.25 nM | 690 | |
| GO/guanine-quadruplex DNA aptamer | Pb2+ | 0.75/6.0 nM L−1 | 0.40 nM L−1 | 691 | |
| CdSe/ZnS QDs/GO | Pb2+ | 0.1–10 nM | 90 pM | 692 | |
| GO | Hg2+ | 1–50 nM | 0.92 nM | 693 | |
| GQDs | Cu2+ | 0–15 μM | 0.226 μM | 694 | |
| GQDs/GO | Pb2+ | Up to 400 nM | 0.6 nM | 695 | |
| Carbon dots/ODN/GO | Hg2+ | 5–200 nM | 2.6 nM | 696 | |
| Dopamine/GQDs | Fe3− | 20 nM to 2 μM | 7.6 nM | 697 | |
| GO-AuNPs | Pb2+ | 2 nM to 0.23 μM | 0.1 nM | 698 | |
| Macroporous GR foam | Pb2+ | 50–500 pM | 50 pM | 699 | |
| Cu2+ | 0.6 nM | ||||
| GQDs | Fe3− | 0 to 60 μM | 0.45 μM | 700 | |
| Pi-A/rGO | Cu2+ | 5–300 μg mL−1 | 0.67 μg mL−1 | 591 | |
| N-doped GQDs | Al3+ | 2.5–75 μM | 1.3 μM | 701 | |
| S-doped GQDs | Ag+ | 0.1–130 μM | 30 nM | 702 | |
| GQDs | Cu2+ | 0.1–1 μM | 0.067 μM | 703 | |
| GQDs/AuNPs | Pb2+ | 50 nM to 4 μM | 16.7 nM | 704 | |
| N-doped GQDs | Hg2+ | 2–200 nM | 0.32 nM | 705 | |
| Pesticides | N-doped GQDs | Omethoate | 0.1–1.7 nM | 0.041 pM | 706 |
| N-doped GQDs MIP | Thiacloprid | 0.1–10 mg L−1 | 0.03 mg L−1 | 707 |
Abbreviations used PVA: poly(vinyl alcohol), PSA: (prostate specific antigen, a cancer marker), GLY: glycine, AFB1: aflatoxin B1, cTnI: cardiac marker antigen troponin I in blood, ATP: adenosine triphosphate, Pi-A: N-(2-(1-(p-tolyl)-1H-phenanthro[9,10-d]imidazol-2-yl)phenyl)picolinamide, CDs: carbon dots, ODN: oligodeoxyribonucleotide, MIP: molecularly imprinted polymer. Upconversion fluorescent NPs: BaY0.78F5:Yb0.2,Er0.02 and BaY0.78F5:Yb0.7,Tm0.02 nanoparticles.